NuCana plc(NASDAQ:NCNA) 
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients wit...
Website: http://www.nucana.com
Founded: 1997
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 174.00
H 178.00
L 150.00
C 158.00
V 132,739
10EMA 158.00
20EMA 158.00
60EMA 158.00
120EMA 158.00
250EMA 158.00